Meltzer, EliRatner, PaulBachert, ClausCarr, WarnerBerger, WilliamCanonica, G. WalterHadley, JamesLieberman, PhilHampel, Frank C.Mullol, JoaquimMunzel, UllrichPrice, DavidScadding, GlenisVirchow, J. ChristianWahn, UlrichMurray, RuthBousquet, Jean2020-06-162020-06-162013-07Meltzer, E, Ratner, P, Bachert, C, Carr, W, Berger, W, Canonica, G W, Hadley, J, Lieberman, P, Hampel, F C, Mullol, J, Munzel, U, Price, D, Scadding, G, Virchow, J C, Wahn, U, Murray, R & Bousquet, J 2013, 'Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis', International Archives of Allergy and Immunology, vol. 161, no. 4, pp. 369-377. https://doi.org/10.1159/0003514041018-2438https://hdl.handle.net/2164/14506Acknowledgements This study was funded by MedaPharma.9245859engAllergic rhinitisAzelastineFluticasoneMP29-02Responder analysisSevere chronic upper airway diseaseR Medicine (General)R1Journal article10.1159/0003514041614